Philadelphia College of Osteopathic Medicine research and development spending, FY2024

  • Philadelphia, PA
  • Private nonprofit
  • Standard form filer

Philadelphia College of Osteopathic Medicine in FY2024

$7.6 million

spent on research and development in FY2024, as reported to the NSF HERD Survey

National rank
#408 of 925
Change on FY2023
up 2.0%
Rank change
down 12

Philadelphia College of Osteopathic Medicine reported $7.6 million of research and development spending in FY2024, ranking #408 of the 925 institutions in the survey. That is up 2.0% on FY2023's $7.5 million; its national rank was down 12 places. Institution funds is its largest funding source at 46.2% ($3.5 million), followed by business at 30.2%. Its largest field of research is life sciences, $7.6 million or 100.0% of the total.

Over time

Research spending, FY2010 to FY2024

Philadelphia College of Osteopathic Medicine research and development expenditures, FY2010 to FY2024A line from $1.3 million in FY2010 to $7.6 million in FY2024. Every plotted figure is in the table below.$0$1.9M$3.8M$5.7M$7.6MFY2010FY2015FY2020FY2024

Standard-form totals FY2010 onwards as revised by NCSES in the newest release; rank is within that series.

Year-by-year figures
Philadelphia College of Osteopathic Medicine research and development expenditures by fiscal year, NSF HERD.
Fiscal yearR&D expenditureRank in series
FY2010$1.3 million515
FY2011$2.4 million464
FY2012$1.9 million503
FY2013$2.6 million452
FY2014$2.2 million470
FY2015$2.6 million453
FY2016$2.5 million464
FY2017$3.0 million449
FY2018$3.1 million450
FY2019$3.2 million458
FY2020$3.4 million452
FY2021$6.2 million382
FY2022$6.7 million385
FY2023$7.5 million396
FY2024$7.6 million407

FY2024 breakdown

Where the money came from, and what it paid for

FY2024 funding sources and research fields

Funding sources

The 4 NSF funding sources Philadelphia College of Osteopathic Medicine reported in FY2024, largest first. Shares are of its own FY2024 total, and the rank is national within that source.

Philadelphia College of Osteopathic Medicine research and development expenditures by funding source, NSF HERD FY2024.
SourceFY2024ShareChange on FY2023US rank
Institution funds$3.5 million46.2%+23.4%350
Business$2.3 million30.2%−9.9%188
Nonprofit organizations$1.6 million20.7%+0.8%242
Federal government$225 thousand3.0%−49.1%788
All sources$7.6 million100.0%+2.0%408

Fields of research

The one NSF research field Philadelphia College of Osteopathic Medicine reported in FY2024.

Philadelphia College of Osteopathic Medicine research and development expenditures by field of research, NSF HERD FY2024.
FieldFY2024ShareChange on FY2023US rank
Life sciences$7.6 million100.0%+2.0%281

Neighbours

Ranked around Philadelphia College of Osteopathic Medicine

Institutions ranked immediately above and below

The five institutions ranked above Philadelphia College of Osteopathic Medicine and the five below it in the FY2024 national ranking.

Institutions ranked immediately above and below Philadelphia College of Osteopathic Medicine, NSF HERD FY2024.
RankInstitutionFY2024 R&D
403Georgia College and State University$8.0M
404Abilene Christian University$7.9M
405Benedict College$7.8M
406Claremont McKenna College$7.8M
407Southern Connecticut State University$7.6M
408Philadelphia College of Osteopathic Medicine$7.6M
409University of Colorado Colorado Springs$7.5M
410Marian University, Indianapolis$7.5M
411Smith College$7.4M
412Norfolk State University$7.3M
413Texas A&M University-San Antonio$7.1M

Benchmark Philadelphia College of Osteopathic Medicine against its peers.

Request a demo

Or see how it pairs with FundFit →

Data: NSF HERD FY2024, built from NSF's published tables on September 8, 2026. Page updated September 13, 2026.

Data: National Center for Science and Engineering Statistics, National Science Foundation, Higher Education Research and Development Survey, FY2024.

Carnegie Classification of Institutions of Higher Education is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.